ArticleDermatology and therapy2024

Long-Term Safety of Risankizumab in Patients with Psoriatic Disease: A Comprehensive Analysis from Clinical Trials.

Kenneth B Gordon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.